Abstract
A number of research have proven that antimicrobial peptides are of greatest potential as a new class of antibiotics. Antimicrobial peptides and cell-penetrating peptides share some similar structure characteristics. In our study, a new peptide analog, APP (GLARALTRLLRQLTRQLTRA) from the cell-penetrating peptide ppTG20 (GLFRALLRLLRSLWRLLLRA), was identified simultaneously with the antibacterial mechanism of APP against Salmonella typhimurium and Streptococcus pyogenes. APP displayed potent antibacterial activity against Gram-negative and Gram-positive strains. The minimum inhibitory concentration was in the range of 2 to 4 μM. APP displayed higher cell selectivity (about 42-fold increase) as compared to the parent peptide for it decreased hemolytic activity and increased antimicrobial activity. The calcein leakage from egg yolk l-α-phosphatidylcholine (EYPC)/egg yolk l-α-phosphatidyl-dl-glycerol and EYPC/cholesterol vesicles demonstrated that APP exhibited high selectivity. The antibacterial mechanism analysis indicated that APP induced membrane permeabilization in a kinetic manner for membrane lesions allowing O-nitrophenyl-β-d-galactoside uptake into cells and potassium release from APP-treated cells. Flow cytometry analysis demonstrated that APP induced bacterial live cell membrane damage. Circular dichroism, fluorescence spectra, and gel retardation analysis confirmed that APP interacted with DNA and intercalated into the DNA base pairs after penetrating the cell membrane. Cell cycle assay showed that APP affected DNA synthesis in the cell. Our results suggested that peptides derived from the cell-penetrating peptide have the potential for antimicrobial agent development, and APP exerts its antibacterial activity by damaging bacterial cell membranes and binding to bacterial DNA to inhibit cellular functions, ultimately leading to cell death.
Similar content being viewed by others
References
Bhardwaj N, Lu H (2007) Residue-level prediction of DNA-binding sites and its application on DNA-binding protein predictions. FEBS Lett 581(5):1058–1066
Chang YM, Chen CKM, Hou MH (2012) Conformational changes in DNA upon ligand binding monitored by circular dichroism. Int J Mol Sci 13:3394–3413
Delcroix M, Riley LW (2010) Cell-penetrating peptides for antiviral drug development. Pharmaceuticals 3(3):448–470
Eduardo GG, Teresa SM, SaúlO LR, Terán LM (2010) Antimicrobial peptides: general overview and clinical implications in human health and disease. Cl Immunol 135(1):1–11
Fiel RJ, Howard JC, Mark EH, Datta GN (1979) Interaction of DNA with a porphyrin ligand: evidence for intercalation. Nucleic Acids Res 6(9):3093–3118
Hansen M, Kilk K, Langel Ü (2008) Predicting cell-penetrating peptides. Adv Drug Deliver Rev 60:572–579
Hao G, Shi YH, Tang YL, Le GW (2009) The membrane action mechanism of analogs of the antimicrobial peptide buforin 2. Peptides 30:1421–1427
Hou F, Li J, Pan P, Xu J, Liu L, Liu W, Song B, Li N, Wan J, Gao H (2011) Isolation and characterisation of a new antimicrobial peptide from the skin of Xenopus laevis. Int J Antimicrob Agents 38(6):510–515
Hugonina L, Vukojević V, Bakalkinb G, Gräslund A (2006) Membrane leakage induced by dynorphins. FEBS Lett 580(13):3201–3205
Ibrahim HR, Sugimoto Y, Aoki T (2000) Ovotransferrin antimicrobial peptide (OTAP-92) kills bacteria through a membrane damage mechanism. Biochim Biophys Acta 1523:196–205
Imura Y, Nishida M, Matsuzaki K (2007a) Action mechanism of PEGylated magainin 2 analogue peptide. Biochim Biophys Acta 1768:2578–2585
Imura Y, Nishida M, Ogawa Y, Takakura Y, Matsuzaki K (2007b) Action mechanism of tachyplesin I and effects of PEGylation. Biochim Biophys Acta 1768:1160–1169
Joshi S, Bisht GS, Rawat DS, Kumar A, Kumar R, Maiti S, Pasha S (2010) Interaction studies of novel cell selective antimicrobial peptides with mode membranes and E. coli ATCC 11775. Biochim Biophys Acta 1798:1864–1875
Lee DG, Kim HN, Park Y, Kim HK, Choi BH, Choi CH, Hahm KS (2002) Design of novel analogue peptides with potent antibiotic activity based on the antimicrobial peptide, HP (2-20), derived from N-terminus of Helicobacter pylori ribosomal protein L1. Biochim Biophys Acta 1598:185–194
Lepecq JB, Paoletti C (1967) A fluorescent complex between ethidium bromide and nucleic acid. J Mol Biol 27(1):87–106
Madani F, Lindberg S, Langel Ü, Futaki S, Gräslund A (2011) Mechanisms of cellular uptake of cell-penetrating peptides. J Biophysics 2011:1–10
Matsuzaki K (1998) Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim Biophys Acta 1376:391–400
Matsuzaki K (2009) Control of cell selectivity of antimicrobial peptides. Biochim Biophys Acta 1788(8):1687–1692
Moss T (2001) DNA–protein interactions: principles and protocols, 2nd edn. Humana, Totowa
Nekhotiaeva N, Elmquist A, Rajarao GK, Hällbrink M, Langel Ü, Good L (2004) Cell entry and antimicrobial properties of eukaryotic cell-penetrating peptides. FASEB J 18(2):394–396
Palm C, Netzereab S, Hällbrink M (2006) Quantitatively determined uptake of cell-penetrating peptides in non-mammalian cells with an evaluation of degradation and antimicrobial effects. Peptides 27(7):1710–1716
Pan LZ, Na J, Xing Z, Fang HJ, Wang GL (2007) Inhibiting effect of melittin on pathogens of crops. Chin Sci Bull 52:639–644
Park CB, Kim HS, Kim SC (1998) Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Bioph Res Co 244:253–257
Park N, Yamanaka K, Tran D, Chandrangsu P, Akers JC, de Leon JC, Morrissette NS, Selsted ME, Tan M (2009) The cell-penetrating peptide, Pep-1, has activity against intracellular chlamydial growth but not extracellular forms of Chlamydia trachomatis. J Antimicrob Chemother 63:115–123
Rittner K, Benavente A, Bompard-Sorlet A, Heitz F, Divita G, Brasseur R, Jacobs E (2002) New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo. Mol Ther 5(2):104–114
Russell AL, Kennedya AM, Spuchesa AM, Venugopal D, Bhonsleb JB, Hicks RP (2010) Spectroscopic and thermodynamic evidence for antimicrobial. Chem Physics Lipids 163:488–497
Sharma S, Khuller GK (2001) DNA as the intracellular secondary target for antibacterial action of human neutrophil peptide-I against Mycobacterium tuberculosis H37Ra. Curr Microbiol 43:74–76
Steen HB, Boye E (1980) Bacterial growth studied by flow cytometry. Cytometry 1(1):32–36
Szoka F, Papahadjopoulos D (1978) Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. P Natl Acad Sci USA 75:4194–4198
Tang YL, Shi YH, Zhao W, Hao G, Le GW (2009) Interaction of MDpep9, a novel antimicrobial peptide from Chinese traditional edible larvae of housefly, with Escherichia coli genomic DNA. Food Chem 115:867–872
Tsao HS, Spinella SA, Lee AT, Elmore DE (2009) Design of novel histone-derived antimicrobial peptides. Peptides 30(12):2168–2173
Wang L, Brown SJ (2006) BindN: a web-based tool for efficient prediction of DNA and RNA binding sites in amino acid sequences. Nucleic Acids Res 34:w243–w248
Wishart DS, Stothard P, Van Domselaar GH (2000) Peptool and genetool: platform-independent tools for biological sequence analysis. Method Mol Biol 132:93–113
Yang ST, Shin SY, Hahm KS, Kim JI (2006) Design of perfectly symmetric Trp-rich peptides with potent and broad-spectrum antimicrobial activities. Int J Antimicrob Ag 27:325–330
Zhu WL, Shin SY (2009) Effects of dimerization of the cell-penetrating peptide Tat analog on antimicrobial activity and mechanism of bactericidal action. J Pept Sci 15(5):345–352
Acknowledgments
This research was funded by the National Natural Science Foundation of China (grant nos. 30871805 and 31172214).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, L., Shi, Y., Cheserek, M.J. et al. Antibacterial activity and dual mechanisms of peptide analog derived from cell-penetrating peptide against Salmonella typhimurium and Streptococcus pyogenes . Appl Microbiol Biotechnol 97, 1711–1723 (2013). https://doi.org/10.1007/s00253-012-4352-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-012-4352-1